Cargando…
Paxlovid associated with decreased hospitalization rate among adults with COVID-19 — United States, April–September 2022
Autores principales: | Shah, Melisa M., Joyce, Brendan, Plumb, Ian D., Sahakian, Sam, Feldstein, Leora R., Barkley, Eric, Paccione, Mason, Deckert, Joseph, Sandmann, Danessa, Gerhart, Jacqueline L., Hagen, Melissa Briggs |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc. on behalf of American Society of Transplantation & American Society of Transplant Surgeons.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833372/ https://www.ncbi.nlm.nih.gov/pubmed/36695616 http://dx.doi.org/10.1016/j.ajt.2022.12.004 |
Ejemplares similares
-
Paxlovid Associated with Decreased Hospitalization Rate Among Adults with COVID-19 — United States, April–September 2022
por: Shah, Melisa M., et al.
Publicado: (2022) -
Health care personnel exposures to subsequently laboratory-confirmed monkeypox patients — Colorado, 2022
por: Marshall, Kristen E., et al.
Publicado: (2022) -
Influenza incidence and vaccine effectiveness during the Southern Hemisphere Influenza season—Chile, 2022
por: Barraza, María Fernanda Olivares, et al.
Publicado: (2022) -
Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19–associated hospitalizations among immunocompromised adults—Nine States, January–September 2021
por: Embi, Peter J., et al.
Publicado: (2022) -
Impact of hospital strain on excess deaths during the COVID-19 pandemic—United States, july 2020–july 2021
por: French, Geoffrey, et al.
Publicado: (2022)